Kino Biotech Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kino Biotech Co Ltd with three other
pharmaceutical manufacturers in Asia:
Vidipha Central Pharmaceutical JSC
sales of 392.49 billion Dong [US$17.23 million]
Uni-Bio Science Group Limited
of Hong Kong
(146.49 million Hong Kong Dollars [US$18.68 million]
of which 59%
was In-house Biological Pharmaceutical Produ), and
Syncom Healthcare Limited
based in India
(1.24 billion Indian Rupees [US$18.71 million]
During the year ended December of 2016, sales at
Kino Biotech Co Ltd were 23.36 million Singapore Dollars (US$17.75 million).
increase of 11.6%
versus 2015, when the company's sales were 20.93 million Singapore Dollars.
This was the third consecutive year of growth at Kino Biotech Co Ltd.
Sales of Others saw an increase
that was more than double the company's growth rate: sales were up
158.8% in 2016, from
361,072.20 Singapore Dollars to 934,566.00 Singapore Dollars.
Not all segments of Kino Biotech Co Ltd experienced an increase in sales in 2016:
sales of Healthcare Patches fell 5.1% to 1.40 million Singapore Dollars.